Skip to main content

Call for Speakers: Deadline Monday 4th November 2024. Submit HERE >

2024 Workshop Programme

Integrative & Personalised Medicine

Loading

GlucoMedix®: an all-natural phytotherapy for the prevention and treatment of the multiple comorbidities of Metabolic Syndrome

06 Jun 2024
Moore
Nutraceuticals

Recently, pharmacology, toxicity and human research were published in multiple peer-reviewed journals. GlucoMedix was compared to Glibenclamide, Enalapril and Atorvastatin producing similar pharmacological effects. Acute and subacute oral toxicity was performed with no toxicity, abnormal clinical chemistry or haematological effects observed. In a six patient case series, GlucoMedix reduced glucose levels and the need for pharmaceuticals in patients with type 2 diabetes. Although multiple prescription drugs are well known for the treatment of individual comorbidities of metabolic syndrome, no drug monotherapy concurrently treats all three comorbidities.

 

Speakers
Dr Armin Schwarzbach, Managing Director & CEO ArminLabs

Hosted by:

Organised by Progressive Communications Ltd in association with The College of Medicine:

PC COM

With thanks to our Supporters:


 

Register

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

 

Book a Stand

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Call for Speakers

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

IPMCongress

Are you interested in speaking at IPM 2025?

Call for Speakers: Deadline Monday 4th November

SUBMIT AN ABSTRACT >

We look forward to welcoming you to London